A Double-blind, Randomized, Shamprocedurecontrolled, Parallel -group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (rexlemestrocel-L) in Patients with Chronic Heart Failure Due to Left Ventricular Systolic Dysfunction of Either Ischemic or Nonischemic Etiology: DREAM HF-1
A Stem-Cell study for people with Heart Failure
Sponsor: Mesoblast Inc.
Enrolling: Male and Female Patients
IRB Number: AAAO3307
U.S. Govt. ID: NCT02032004
Contact: Yonandy Barrientos: 212-305-1368 / caccresearch@cumc.columbia.edu
Additional Study Information: In this study, patients with heart failure, will undergo a cardiac catheterization procedure which either includes injections of stem cells from healthy young adults into the heart or a sham (mock) procedure that does not include injection of the stem cells. This is a study of an experimental product called rexlemestrocel-L.
This study is closed
Investigator
Maryjane Farr, MD
Do You Qualify?
Do you have heart failure? Yes No
Do you have an LVAD or heart transplant? Yes No
Have you ever been in a trial where you received stem cells? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Yonandy Barrientos
caccresearch@cumc.columbia.edu
212-305-1368
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE